COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 461
[87] Fujinami RS, et al. Molecular mimicry, bystander activation, or
viral persistence: infections and autoimmune disease. Clin
Microbiol Rev. 2006;19(1):80-94.
[88] Lanz TV, et al. Clonally expanded B cells in multiple sclerosis
bind EBV EBNA1 and GlialCAM. Nature. 2022;603(7900):321-327.
[89] Dalmau J, et al. Clinical experience and laboratory
investigations in patients with anti-NMDAR encephalitis. Lancet
Neurol. 2011;10(1):63-74.
[90] Franke C, et al. High frequency of cerebrospinal fluid
autoantibodies in COVID-19 patients with neurological symptoms.
Brain Behav Immun. 2021;93:415-419.
[91] Johnson DR, et al. A systematic review and meta-analysis of
neuroimaging in pediatric obsessive-compulsive disorder. Prog
Neuropsychopharmacol Biol Psychiatry. 2019;92:188-196.
[92] Rupprecht TA, et al. The pathogenesis of lyme neuroborreliosis:
from infection to inflammation. Mol Med. 2008;14(3-4):205-212.
[93] Smatti MK, et al. Viruses and autoimmunity: a review on the
potential interaction and molecular mechanisms. Viruses.
2019;11(8):762.
[94] Aschner M, et al. Involvement of glutamate and reactive
oxygen species in methylmercury neurotoxicity. Braz J Med Biol
Res. 2007;40(3):285-291.
[95] Brewer JH, et al. Detection of mycotoxins in patients with
chronic fatigue syndrome. Toxins (Basel). 2013;5(4):605-617.
[96] El-Fawal HA, et al. Exposure to methylmercury results in serum
autoantibodies to neurotypic and gliotypic proteins.
Neurotoxicology. 1996;17(2):267-276.
[97] Kilburn KH. Chemical brain injury. New York: Van Nostrand
Reinhold; 1998:399-422.
461
